News
-
-
-
COMMUNIQUÉ DE PRESSE
ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment -
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty
Heidelberg Pharma receives USD 25 million upfront cash payment from HealthCare Royalty for royalty purchase agreement. Funds to advance ADC pipeline development and extend cash runway -
-
-
COMMUNIQUÉ DE PRESSE
INTILION receives second largest order in the company's history from energy start-up Purpel Energy
INTILION receives second largest order in the company's history from energy start-up Purpel Energy for large-scale energy storage projects in northern Germany, improving renewable energy integration and grid stability -
-
COMMUNIQUÉ DE PRESSE
Advanced Blockchain AG presents a strong 2023 despite a difficult market environment
Advanced Blockchain AG reports strong 2023 results with revenue of 5.2m € and EBIT of 2.2m €. Top 10 portfolio value increased by over 45%. CEO emphasizes focus on efficiency and business model development -
